Drug Trial Radar · NCT00524433
Tezosentan in the Treatment of Acute Heart Failure
Last checked: Nov 20, 2026Latest source record: Jul 10, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
713
Actual
Start
Apr 2003
Primary completion
Jan 2005
Study completion Jan 2005
Sponsor
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 3, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The randomized patients with acute heart failure will be stratified based on the presence or absence of a Swan-Ganz catheter and assigned to receive either tezosentan 5 mg/h for the first 30 minutes and 1 mg/h thereafter or matching placebo in a 1:1 manner. The duration of the treatment is 24 hours up to 72 hours. The duration of the follow-up period is 30 days after treatment initiation for death, re-hospitalizations and SAEs followed by a follow-up period of 5 months for vital status.
Conditions
- Acute Heart Failure
- Acute Decompensation of Chronic Heart Failure
- New Onset of Heart Failure
Interventions
tezosentanDrug
tezosentan delivered i.v. at 20 mL/h (5 mg/h) for 30 min followed by 4 mL/h (1 mg/h) for 23.5 to 71.5 h (24 to 72 h in total)
placeboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of death or worsening heart failureTime frame: within 7 days following study drug initiation
Locations
42 sites in 8 countries. Site status is shown where the registry gives one.
Oracle Research
Huntsville, Alabama
USC Medical Center
Los Angeles, California
Jacksonville Center for Clinical Research
Jacksonville, Florida
University of Miami-Jackson Memorial Hospital
Miami, Florida
University Hospital
Augusta, Georgia
University of Iowa Hospital and Clinics
Iowa City, Iowa
Medical Research Institute
Slidell, Louisiana
Baystate Medical Center-Cardiology Section
Springfield, Massachusetts
Elmhurst Hospital Center
Elmhurst, New York
Columbia Presbyterian Medical Center-Heart Failure Center
New York, New York
New York University School of Medicine
New York, New York
University of North Carolina
Chapel Hill, North Carolina
Duke University Medical Center
Durham, North Carolina
LeBauer Cardiovascular Research Foundation
Greensboro, North Carolina
Baylor College of Medicine - Texas Medical Center
Houston, Texas
University of Texas, MD Anderson Cancer Center
Houston, Texas
Concord Repatriation Hospital
Concord NSW, Australia
Queen Elizabeth Hospital
Woodville SA, Australia
Alfred Hospital, Monash University, Central and Eastern School
Prahran, Victoria, Australia
Faculty Hospital St. Anna
Brno, Czechia
Krajska Nemocnice Liberec
Liberec, Czechia
Klinika Kardiologie IKEM
Prague, Czechia
University Hospital Vinohrady (FNKV)
Prague, Czechia
Masaryk Hospital
Ústí nad Labem, Czechia
Universitatsklinikum der Humboldt-Universitat Berlin, Campus Charite Mitte, Med. Klinik und Poliklinik, Kardiologie
Berlin, Germany
Universitat Greifswald, Klinik fur Innere Medizin B
Greifswald, Germany
Asklepios Klinik Langen, Abteilung fur Innere Medizin
Langen, Germany
Universitatsklinikum Schleswig Holstein, Medizinische Klinik II, Kardiologie
Lübeck, Germany
Klinik u. Poliklinik F. Inn. Med. II, Univ. Klinik Regensburg
Regensburg, Germany
Jahn Ferenc, Delpesti Korhaz
Budapest, Hungary
Polyclinic of the Hospitaler Brothers of St. John of God
Budapest, Hungary
University of Debrecen
Debrecen, Hungary
2nd Department of Medicine & Cardiology Centre
Szeged, Hungary
Cattedra di Cardiologia, c/o Spedali Civili
Brescia, Italy
Istituto Clinico Humanitas, U.O. Cardiologia Clin. E Insuff. Cardiaca
Rozzano (MI), Italy
Sentralsykehuset i More og Romsdal, Dept. of Cardiology
Ålesund, Norway
Aker University Hospital, Div. Cardiology
Oslo, Norway
Central Hospital in Rogaland, Cardiology Division
Stavanger, Norway
University Department of Medicine, City Hospital
Birmingham, United Kingdom
Cardiology Department, Bridlington & District Hospital
Bridlington, United Kingdom
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.